Guardian Pharmacy Services, Inc. (GRDN) stock
Close on Nov 11, 2026Market cap $3.17BP/E –Yield –
Guardian Pharmacy Services, Inc. grew revenue 4.9% to $1.46B over the twelve months to Sep 30, 2026. Operating income rose 60.4% to $94.14M, moving the operating margin from 4.2% to 6.5%. Free cash flow was $86.84M, up 100.8% from a year earlier. At the latest close the market valued the company at $3.17B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $3.17B
- P/E ratio
- –
- Price to sales
- 2.17
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.46B
- Net income
- $74.77M
- Free cash flow
- $86.84M
- Diluted shares
- 64M
Trading
- Next earnings
- Mar 10, 2027 (estimated, during market hours)
- Previous close
- $49.85
- Open
- $49.75
- Day's range
- $49.01 – $50.59
- Volume
- 662,593
- Average volume (20 days)
- 511,372
- Index membership
- Russell 2000 (since Dec 2024), Russell 3000 (since Feb 2025)
- Beta (5 years)
- 0.56
- 52-week range
- $26.34 – $50.59
- RSI (14 days)
- 73.2
- Volatility (1 year)
- 43.3%
- Relative volume
- 1.39×
- WACC
- 7.7%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | GRDN | S&P 500 | Difference | GRDN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +21.1% | -2.4% | +23.5 pts | ||
| 3 months | +26.7% | -1.2% | +27.8 pts | ||
| Year to date | +66.1% | +12.3% | +53.8 pts | ||
| 1 year | +59.9% | +12.4% | +47.5 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
Free cash flow
Press releases
Releases Guardian Pharmacy Services filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Results
About Guardian Pharmacy Services
Retail-Drug Stores and Proprietary Stores
Guardian Pharmacy Services, Inc. provides comprehensive, technology-enabled pharmacy services tailored primarily for residents of long-term care facilities. The company specializes in individualized clinical care, automated robotic drug dispensing, compliance packaging, and medication administration support. Its operations focus primarily on serving assisted living facilities, behavioral health communities, and group homes, while also supporting residents in skilled nursing facilities. In addition to dispensing pharmaceuticals, the company coordinates prescription benefit plan coverage, integrates with electronic medication administration records, and delivers caregiver training, consulting services, and regulatory compliance audits.
Company profile, executives and historyGuardian Pharmacy Services stock: common questions
What is Guardian Pharmacy Services's stock price?
GRDN closed at $49.98 on Nov 11, 2026, up 0.26% on the day. Over the past 52 weeks it traded between $26.34 and $50.59.
What is Guardian Pharmacy Services's market cap?
Guardian Pharmacy Services was worth $3.17B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
How much revenue does Guardian Pharmacy Services make?
Guardian Pharmacy Services reported revenue of $1.46B for the twelve months to Sep 30, 2026, up 4.9% from a year earlier.
Does Guardian Pharmacy Services pay a dividend?
No. Guardian Pharmacy Services has not paid a cash dividend over the last twelve months.
When does Guardian Pharmacy Services report earnings next?
Guardian Pharmacy Services is expected to report Q4 FY2026 results on Mar 10, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has GRDN stock performed over the past year?
Including dividends, GRDN returned +59.9% over the past year, against +12.4% for the S&P 500.
How many GRDN shares are sold short?
2M shares were sold short at the latest FINRA report, 6.17% of the float, or 6.6 days of average trading volume.
Who are Guardian Pharmacy Services's competitors?
Companies most similar to Guardian Pharmacy Services by business, industry and size include NHC, PETS, YI, LESLQ, OMCL.
See a number that looks wrong?